Plasma Metanephrines Clinical Trials
- Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov Identifier: NCT00258245 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- PS-341 in Treating Patients With Refractory or Progressive Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049478 - Active, not recruiting
refractory plasma cell neoplasm
- A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART
ClinicalTrials.gov Identifier: NCT00000874 - Active, not recruiting
HIV Infections
- AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00022282 - Active, not recruiting
refractory plasma cell neoplasm
- Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation
ClinicalTrials.gov Identifier: NCT00003153 - Active, not recruiting
refractory plasma cell neoplasm
- Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
ClinicalTrials.gov Identifier: NCT00416897 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm; Renal Failure
- Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
ClinicalTrials.gov Identifier: NCT00258258 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00003512 - Active, not recruiting
refractory plasma cell neoplasm; Waldenstrom's Macroglobulinemia
- Epoetin alfa in Treating Anemia in Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00058331 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Epoetin alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00090935 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Low-Intensity Preparation and Allogeneic Transplant in Patients with Cancers of the Blood
ClinicalTrials.gov Identifier: NCT00146055 - Active, not recruiting
Myeloma, Plasma-Cell; Lymphoma, Malignant; Myeloproliferative Disorders; Myelodysplastic Syndromes; Waldenstrom''s Macroglobulinemia
- Darbepoetin alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00070382 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00060203 - Active, not recruiting
stage III multiple myeloma; refractory plasma cell neoplasm
- High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
ClinicalTrials.gov Identifier: NCT00002630 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004903 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003490 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00112723 - Recruiting
Leukemia; Lymphoma; plasma cell neoplasm
- Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion
ClinicalTrials.gov Identifier: NCT00360919 - Active, not recruiting
Food Habits
- Platelet Rich Plasma Study in Lower Extremity Bypass Surgery
ClinicalTrials.gov Identifier: NCT00517452 - Active, not recruiting
Atherosclerosis
- Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
ClinicalTrials.gov Identifier: NCT00004645 - Active, not recruiting
Acute Disseminated Encephalomyelitis; Devic's Syndrome; Marburg's variant of multiple sclerosis; Balo's Concentric Sclerosis; ...
- Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products
ClinicalTrials.gov Identifier: NCT00455585 - Active, not recruiting
HIV Infections
- R115777 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00021203 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Sorafenib in Treating Patients with Metastatic Or Unresectable Solid Tumors, Multiple Myeloma, Or Non-Hodgkin''s Lymphoma with Or Without Impaired Liver Or Kidney Function
ClinicalTrials.gov Identifier: NCT00118170 - Active, not recruiting
adult non-Hodgkin''s lymphoma; adult solid tumor; Multiple Myeloma; refractory plasma cell neoplasm
- Melphalan, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003954 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Combination Chemotherapy With or Without Thalidomide in Treating Patients With Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005834 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Plasma Exchange for Autoimmune Autonomic Failure
ClinicalTrials.gov Identifier: NCT00359346 - Recruiting
Plasma Exchange; Autonomic Failure
- Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00066638 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- CI-994 in Treating Patients With Advanced Myeloma
ClinicalTrials.gov Identifier: NCT00005624 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003603 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Arsenic Trioxide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00017433 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005792 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00006225 - Active, not recruiting
Breast Cancer; Leukemia; Lymphoma; Male Breast Cancer; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
- Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006890 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00014508 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Acute Single Meal Effects of Trout on Cardiovascular Risk Markers and Plasma Proteome
ClinicalTrials.gov Identifier: NCT00432952 - Active, not recruiting
Cardiovascular Diseases; Metabolic Syndrome
- Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00044954 - Active, not recruiting
Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
- Prospective, Randomized, Multi-Center Clinical Study of Plasma Disc Decompression Efficacy
ClinicalTrials.gov Identifier: NCT00189605 - Active, not recruiting
Radicular Pain Secondary to Focal Disc Protrusion
- Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00068523 - Active, not recruiting
chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
- Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00017069 - Active, not recruiting
refractory plasma cell neoplasm; stage II multiple myeloma; stage III multiple myeloma
- Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004158 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; stage I multiple myeloma; refractory plasma cell neoplasm
- Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
ClinicalTrials.gov Identifier: NCT00008307 - Active, not recruiting
childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm
- Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004165 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis
- Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00124605 - Active, not recruiting
unspecified adult solid tumor, protocol specific; refractory plasma cell neoplasm; stage III multiple myeloma; stage II multiple myeloma
- Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
ClinicalTrials.gov Identifier: NCT00003538 - Active, not recruiting
Leukemia; Lymphoma; Plasma Cell Neoplasm; Aplastic Anemia; Solid Tumor; Graft Versus Host Disease
- Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction
ClinicalTrials.gov Identifier: NCT00054483 - Recruiting
adult non-Hodgkin's lymphoma; adult solid tumor; Multiple Myeloma; refractory plasma cell neoplasm
- Darbepoetin alfa in Treating Anemia in Patients With Non-Myeloid Cancer Who Are Not Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00098696 - Recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
ClinicalTrials.gov Identifier: NCT00176475 - Recruiting
Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
- Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00316940 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00317811 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon alfa in Treating Patients With Advanced Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006244 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Reference Values for Plasma Catechols
ClinicalTrials.gov Identifier: NCT00267904 - Recruiting
Catecholamine
- Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00227682 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00255749 - Active, not recruiting
Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00296023 - Active, not recruiting
Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
- Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00045136 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- High-Dose Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Amyloidosis
ClinicalTrials.gov Identifier: NCT00002810 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00301951 - Active, not recruiting
Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
- Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00046852 - Active, not recruiting
Infection; refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Effectiveness of Plasma Transfusions in Critical Care Patients
ClinicalTrials.gov Identifier: NCT00302965 - Recruiting
Coagulation
- Actretin Plasma Levels Under Hemodialysis
ClinicalTrials.gov Identifier: NCT00488384 - Recruiting
Carcinoma, Squamous Cell
- Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studiess
ClinicalTrials.gov Identifier: NCT00114647 - Recruiting
- Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides
ClinicalTrials.gov Identifier: NCT00187733 - Recruiting
Healthy
- Vaccine Therapy Plus Donor Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00020306 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2
ClinicalTrials.gov Identifier: NCT00252525 - Active, not recruiting
Type 2 Diabetes Mellitus
- Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
ClinicalTrials.gov Identifier: NCT00530218 - Active, not recruiting
Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
- Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione
ClinicalTrials.gov Identifier: NCT00228644 - Recruiting
Healthy
- COMPACT - COMbining Plasma-Filtration and Adsorption Clinical Trial
ClinicalTrials.gov Identifier: NCT00332371 - Recruiting
Shock, Septic
- Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
ClinicalTrials.gov Identifier: NCT00082784 - Recruiting
adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma; refractory plasma cell neoplasm
- Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer
ClinicalTrials.gov Identifier: NCT00248430 - Active, not recruiting
Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
- Tandem Autologous Stem Cell Transplantation With or Without Maintenance Therapy After the Second Transplantation Compared With Autologous Stem Cell Transplantation Followed By Matched Sibling Allogeneic Stem Cell Transplantation in Patients With Stage II
ClinicalTrials.gov Identifier: NCT00075829 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00104923 - Recruiting
Hodgkin's lymphoma; acute leukemia; chronic leukemia; chronic myeloproliferative disorders; Non-Hodgkin's Lymphoma; plasma cell neoplasm
- Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
ClinicalTrials.gov Identifier: NCT00482378 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm; Pain
- Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine
ClinicalTrials.gov Identifier: NCT00581932 - Recruiting
Schizophrenia
- Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness
ClinicalTrials.gov Identifier: NCT00573950 - Recruiting
Diabetes Mellitus, Type 2; Metabolic Syndrome X
- Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity
ClinicalTrials.gov Identifier: NCT00573118 - Active, not recruiting
Pregnancy Complications; Preeclampsia; Placental Abruption; Intrauterine Fetal Growth Restriction; Intrauterine Fetal Death
- Follow-Up of Patients With Breast Cancer or Multiple Myeloma Previously Treated on a Gene Therapy Clinical Trial
ClinicalTrials.gov Identifier: NCT00427726 - Active, not recruiting
Breast Cancer; Multiple Myeloma and Plasma Cell Neoplasm
- Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis
ClinicalTrials.gov Identifier: NCT00375635 - Recruiting
Uremia
- Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels
ClinicalTrials.gov Identifier: NCT00441480 - Recruiting
Dyslipidemia
- Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity
ClinicalTrials.gov Identifier: NCT00523562 - Recruiting
Metabolic Syndrome X; Liver Diseases
- Plasma Determination of Glucagon-Like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure
ClinicalTrials.gov Identifier: NCT00180648 - Recruiting
Short Bowel Syndrome
- The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
ClinicalTrials.gov Identifier: NCT00247702 - Recruiting
Deep Venous Thromboembolism
- Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00564889 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00253578 - Recruiting
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
- G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
ClinicalTrials.gov Identifier: NCT00253552 - Active, not recruiting
Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Sarcoma
- Antineoplaston Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003511 - Recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00085345 - Recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Total-Body Irradiation With Or Without Fludarabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00075478 - Recruiting
childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00290628 - Active, not recruiting
Chronic Myeloproliferative Disorders; Diamond-Blackfan Anemia; Fanconi Anemia; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
ClinicalTrials.gov Identifier: NCT00547365 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Prevention of Graft-Versus-Host Disease Following Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00019851 - Active, not recruiting
Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
- Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases
ClinicalTrials.gov Identifier: NCT00376922 - Active, not recruiting
Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Pain; Psychosocial Effects/Treatment
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
ClinicalTrials.gov Identifier: NCT00365287 - Active, not recruiting
Breast Cancer; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
- Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
ClinicalTrials.gov Identifier: NCT00544115 - Active, not recruiting
Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition
- Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers
ClinicalTrials.gov Identifier: NCT00175071 - Recruiting
Hyperlipidemias; Metabolic Syndrome X; Cardiovascular Diseases
- Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
ClinicalTrials.gov Identifier: NCT00520767 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- The Effect of Fruit and Fruit Juice on Plasma Total Antioxidant Capacity
ClinicalTrials.gov Identifier: NCT00545415 - Recruiting
Healthy
- Plasma Brain Natriuretic Peptide Levels in Pregnancy
ClinicalTrials.gov Identifier: NCT00324402 - Recruiting
Cardiomyopathy; Pregnancy
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
